#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Erythema multiforme Cutaneous T-cell lymphoma recurrent Bone marrow disorder Leukoencephalopathy Chemical burn Lymphatic malformation Mantle cell lymphoma Sjogren's syndrome Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Infertility male Gaucher's disease type I Thermal burn Cardiac arrest Hepatocellular carcinoma CDKL5 deficiency disorder More trials…

    Learn about Rare Diseases

    Arterial tortuosity syndrome – Treatment Crigler-Najjar syndrome – Life with Disease Arterial tortuosity syndrome – Basic Information X-linked lymphoproliferative syndrome – Life with Disease Cholangitis sclerosing – Basic Information Encephalitis autoimmune – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Treatment VEXAS syndrome – Diagnostics Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Angiosarcoma recurrent – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Cromoglicate Oseltamivir Isoflurane 68Ganota-Anti-Her2 Vhh1 Azetukalner Human Cancellous Bone CHLORMADINONE ACETATE GSKVX000000070965 SULBACTAM SODIUM Idursulfase Micronised Spironolactone Donanemab 177Lu-Rhpsma-10.1 Lebrikizumab Ipatasertib Tobevibart Ulipristal Acetate Cefalexin Monohydrate Oxaliplatin FIBRIN More therapies…

    Learn about Your Condition

    Arthralgia Phenylketonuria Lymphocytic leukaemia Solitary fibrous tumour Neuromyopathy Blood disorder Osteochondrodysplasia Hodgkin's disease Breast cancer recurrent Vulvovaginal discomfort Narcolepsy Acute coronary syndrome Haemoptysis Abdominal pain Cold urticaria More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Migraine

  • Study of IPN10200 compared to placebo for prevention of episodic or chronic migraine in adults

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Clostridium Botulinum, Neurotoxin Serotype A/B
    Czechia France Germany Poland Spain

  • Study of rimegepant for preventing chronic migraine in adolescents aged 12 to 17 years

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Migraine
    Czechia Finland Hungary Italy Poland Slovakia +1

  • Study of Rimegepant for Prevention of Menstrual Migraine in Women Aged 18-45 Years

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Rimegepant
    Denmark Germany Italy The Netherlands Poland Spain

  • Study on the Effects of Cilostazol on Headaches in Men and Women with Migraine Without Aura

    Not recruiting

    1 1 1
    Investigated Drugs:
    • CILOSTAZOL
    • Ibuprofen
    • Sumatriptan Succinate
    Denmark

  • Study on Rimegepant and Capsaicin for Migraine in Lean and Obese Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Migraine
    • Obesity
    Investigated Drugs:
    • Rimegepant
    • Capsaicin
    The Netherlands

  • Study on Diclofenac Potassium and Rimegepant for Treating Migraine in Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • DICLOFENAC POTASSIUM
    • Rimegepant
    Denmark
Previous Page
1 … 3 4 5 6 7 8
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!